Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
SFDA issues new regulations for Narcotic Drugs and Psychotropic Drugs
11/21/2005
The State Food and Drug Administration (SFDA) issued on October 31, 2005 "Requirements for the Distribution of Narcotic Drugs and Psychotropic Drugs (Interim)", which took effect on the date of its promulgation. The Requirements comprise five chapters: general provisions, designated distributors, purchase and sales, management and supplementary provisions.
The SFDA also issued on the same date "Requirements for the Manufacturing of Narcotic Drugs and Psychotropic Drugs (Interim)", which took effect on the date of its promulgation. The Requirements comprise six chapters: general provisions, designated manufacturers, production plans, safety management, sales management and supplementary provisions.
The agency issued on November 1, 2005 Notice of the Requirements for the Experimental Research on Narcotic Drugs and Psychotropic Drugs in accordance with Regulations for the Control of Narcotic Drugs and Psychotropic Drugs of the State Council.
Relate News
more
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit